Xencor IncNASDAQ:XNCR
- LAST PRICE35.7200
- TODAY'S CHANGE (%)-0.9000 (-2.4577%)
- Bid / Lots35.2500/ 1
- Ask / Lots36.3000/ 10
- Open / Previous Close36.5500 / 36.6200
- Day Range
- 52 Week Range
- Volume414,213
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XNCR |
|---|---|---|
| 09:32 ET | 6907 | 36.05 |
| 09:35 ET | 100 | 36.125 |
| 09:37 ET | 600 | 35.82 |
| 09:39 ET | 850 | 36.01 |
| 09:42 ET | 1400 | 36.425 |
| 09:44 ET | 500 | 36.42 |
| 09:46 ET | 101 | 36.3675 |
| 09:48 ET | 2169 | 36.315 |
| 09:51 ET | 1100 | 36.555 |
| 09:53 ET | 3750 | 36.835 |
| 09:55 ET | 2311 | 36.69 |
| 09:57 ET | 500 | 36.64 |
| 10:00 ET | 1400 | 36.6459 |
| 10:02 ET | 300 | 36.68 |
| 10:04 ET | 100 | 36.635 |
| 10:06 ET | 4547 | 36.57 |
| 10:08 ET | 675 | 36.695 |
| 10:09 ET | 1600 | 36.55 |
| 10:11 ET | 100 | 36.42 |
| 10:13 ET | 12374 | 36.38 |
| 10:18 ET | 4855 | 36.75 |
| 10:20 ET | 600 | 36.805 |
| 10:22 ET | 5440 | 36.68 |
| 10:24 ET | 100 | 36.62 |
| 10:27 ET | 500 | 36.676 |
| 10:29 ET | 208 | 36.61 |
| 10:31 ET | 200 | 36.67 |
| 10:33 ET | 1182 | 36.83 |
| 10:36 ET | 200 | 36.87 |
| 10:38 ET | 1505 | 36.84 |
| 10:40 ET | 100 | 36.845 |
| 10:42 ET | 100 | 36.82 |
| 10:44 ET | 100 | 36.845 |
| 10:47 ET | 200 | 36.85 |
| 10:49 ET | 1400 | 36.91 |
| 10:51 ET | 600 | 36.97 |
| 10:54 ET | 1400 | 36.795 |
| 10:56 ET | 100 | 36.81 |
| 11:00 ET | 100 | 36.78 |
| 11:02 ET | 713 | 36.785 |
| 11:03 ET | 1099 | 36.715 |
| 11:05 ET | 200 | 36.545 |
| 11:09 ET | 600 | 36.63 |
| 11:14 ET | 1200 | 36.56 |
| 11:16 ET | 700 | 36.48 |
| 11:21 ET | 600 | 36.23 |
| 11:27 ET | 1100 | 36.145 |
| 11:30 ET | 700 | 36.1 |
| 11:32 ET | 350 | 36.0848 |
| 11:34 ET | 1400 | 36.16 |
| 11:36 ET | 200 | 36.205 |
| 11:38 ET | 1181 | 36.3 |
| 11:39 ET | 900 | 36.275 |
| 11:41 ET | 200 | 36.41 |
| 11:43 ET | 1100 | 36.34 |
| 11:48 ET | 500 | 36.36 |
| 11:50 ET | 888 | 36.42 |
| 11:52 ET | 100 | 36.37 |
| 11:54 ET | 900 | 36.44 |
| 11:56 ET | 100 | 36.46 |
| 11:57 ET | 700 | 36.415 |
| 11:59 ET | 3452 | 36.44 |
| 12:01 ET | 712 | 36.49 |
| 12:03 ET | 200 | 36.52 |
| 12:06 ET | 219 | 36.51 |
| 12:08 ET | 1100 | 36.42 |
| 12:10 ET | 574 | 36.42 |
| 12:12 ET | 1200 | 36.49 |
| 12:14 ET | 100 | 36.475 |
| 12:15 ET | 100 | 36.475 |
| 12:19 ET | 100 | 36.475 |
| 12:21 ET | 300 | 36.26 |
| 12:24 ET | 300 | 36.19 |
| 12:26 ET | 200 | 36.08 |
| 12:28 ET | 300 | 36.05 |
| 12:30 ET | 100 | 35.935 |
| 12:32 ET | 700 | 35.935 |
| 12:33 ET | 300 | 35.925 |
| 12:35 ET | 700 | 35.955 |
| 12:39 ET | 100 | 35.95 |
| 12:42 ET | 3349 | 36.05 |
| 12:44 ET | 900 | 35.92 |
| 12:46 ET | 3601 | 36.08 |
| 12:48 ET | 500 | 36.19 |
| 12:50 ET | 400 | 36.23 |
| 12:51 ET | 100 | 36.17 |
| 12:53 ET | 1300 | 36.18 |
| 12:55 ET | 683 | 36.19 |
| 12:57 ET | 300 | 36.2 |
| 01:00 ET | 494 | 36.115 |
| 01:02 ET | 979 | 36.15 |
| 01:06 ET | 600 | 36.04 |
| 01:08 ET | 100 | 36.04 |
| 01:09 ET | 372 | 36.03 |
| 01:13 ET | 500 | 36.01 |
| 01:15 ET | 1604 | 35.87 |
| 01:18 ET | 100 | 35.85 |
| 01:20 ET | 400 | 35.85 |
| 01:22 ET | 500 | 35.88 |
| 01:24 ET | 1223 | 35.83 |
| 01:26 ET | 581 | 35.785 |
| 01:27 ET | 4700 | 35.8 |
| 01:29 ET | 2200 | 35.8 |
| 01:31 ET | 3800 | 35.89 |
| 01:33 ET | 4709 | 35.75 |
| 01:36 ET | 400 | 35.67 |
| 01:38 ET | 100 | 35.62 |
| 01:40 ET | 100 | 35.67 |
| 01:42 ET | 500 | 35.64 |
| 01:44 ET | 1676 | 35.53 |
| 01:45 ET | 478 | 35.4999 |
| 01:47 ET | 300 | 35.42 |
| 01:49 ET | 1892 | 35.285 |
| 01:51 ET | 1149 | 35.44 |
| 01:54 ET | 918 | 35.5 |
| 01:56 ET | 600 | 35.54 |
| 02:00 ET | 748 | 35.49 |
| 02:02 ET | 985 | 35.62 |
| 02:03 ET | 300 | 35.615 |
| 02:07 ET | 1300 | 35.65 |
| 02:12 ET | 300 | 35.65 |
| 02:14 ET | 100 | 35.72 |
| 02:16 ET | 850 | 35.66 |
| 02:18 ET | 1600 | 35.67 |
| 02:21 ET | 700 | 35.55 |
| 02:23 ET | 500 | 35.64 |
| 02:25 ET | 800 | 35.75 |
| 02:27 ET | 257 | 35.69 |
| 02:30 ET | 500 | 35.65 |
| 02:32 ET | 100 | 35.65 |
| 02:34 ET | 2135 | 35.7555 |
| 02:36 ET | 300 | 35.65 |
| 02:38 ET | 124 | 35.64 |
| 02:39 ET | 400 | 35.63 |
| 02:43 ET | 300 | 35.71 |
| 02:45 ET | 1085 | 35.71 |
| 02:48 ET | 540 | 35.73 |
| 02:50 ET | 500 | 35.75 |
| 02:52 ET | 500 | 35.63 |
| 02:54 ET | 1140 | 35.6 |
| 02:56 ET | 900 | 35.685 |
| 02:57 ET | 100 | 35.66 |
| 03:01 ET | 1100 | 35.73 |
| 03:03 ET | 500 | 35.68 |
| 03:06 ET | 540 | 35.63 |
| 03:08 ET | 200 | 35.595 |
| 03:10 ET | 700 | 35.53 |
| 03:12 ET | 300 | 35.53 |
| 03:14 ET | 200 | 35.54 |
| 03:15 ET | 1000 | 35.58 |
| 03:17 ET | 200 | 35.55 |
| 03:19 ET | 300 | 35.57 |
| 03:21 ET | 800 | 35.605 |
| 03:24 ET | 819 | 35.59 |
| 03:26 ET | 800 | 35.56 |
| 03:28 ET | 1000 | 35.57 |
| 03:30 ET | 2328 | 35.695 |
| 03:32 ET | 600 | 35.66 |
| 03:33 ET | 400 | 35.6 |
| 03:35 ET | 1743 | 35.57 |
| 03:37 ET | 590 | 35.58 |
| 03:39 ET | 1128 | 35.63 |
| 03:42 ET | 1800 | 35.615 |
| 03:44 ET | 400 | 35.64 |
| 03:46 ET | 500 | 35.64 |
| 03:48 ET | 2062 | 35.71 |
| 03:50 ET | 700 | 35.715 |
| 03:51 ET | 1735 | 35.81 |
| 03:53 ET | 16888 | 35.91 |
| 03:55 ET | 5034 | 35.81 |
| 03:57 ET | 17398 | 35.7 |
| 04:00 ET | 17230 | 35.72 |
Today
Xencor to Present at the SVB Securities Global Biopharma Conference, from 4 hours ago by Business Wire
4 hours ago by Business Wire
Yesterday
Atreca, Xencor to Develop T-Cell Engaging Bispecific Antibody Targeting Solid Tumors, from 2:30PM ET on Monday Feb 06, 2023 by MT Newswires
2:30PM ET on Monday Feb 06, 2023 by MT NewswiresAtreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target, from 8:00AM ET on Monday Feb 06, 2023 by GlobeNewswire
8:00AM ET on Monday Feb 06, 2023 by GlobeNewswire
Jan 30, 2023
EF Hutton Initiates Coverage on Xencor at Buy With $42 Price Target, from 9:34AM ET on Monday Jan 30, 2023 by MT Newswires
9:34AM ET on Monday Jan 30, 2023 by MT Newswires
Jan 9, 2023
BRIEF-Xencor Highlights 2023 Corporate Priorities And Provides Portfolio Updates, from 8:43AM ET on Monday Jan 09, 2023 by Thomson Reuters
8:43AM ET on Monday Jan 09, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xencor Inc | 2.2B | 76.6x | +5.11% |
FibroGen Inc | 2.3B | -6.5x | --- |
Veracyte Inc | 1.8B | -43.3x | --- |
Myovant Sciences Ltd | 2.6B | -14.0x | --- |
CureVac NV | 2.0B | -13.5x | --- |
BioCryst Pharmaceuticals Inc | 2.0B | -10.2x | --- |
Company Information
Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibodies and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company is advancing a portfolio of clinical-stage XmAb drug candidates from its protein engineering technology platforms. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design technologies and XmAb development candidates with properties. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Tidutamab, XmAb841, XmAb306, AMG 509, XmAb819, XmAb104, XmAb564 and Novartis XmAb.
Contact Information
- Headquarters
- 111 W Lemon AveMONROVIA, CA, United States 91016-2809
- Phone
- 626-305-5900
- Fax
- 626-305-0350
Executives
- President, Chief Executive Officer, Founder and Director
- Bassil Dahiyat
- Chief Financial Officer, Senior Vice President
- John Kuch
- Senior Vice President - Research and Chief Scientific Officer
- John Desjarlais
- Senior Vice President, General Counsel, Company Secretary
- Celia Eckert
- Senior Vice President, Chief Medical Officer
- Allen Yang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
|---|---|
Revenue (TTM) | $297.0M |
Shares Outstanding | 59.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.82 |
EPS | $0.47 |
Book Value | $12.36 |
P/E Ratio | 76.6x |
Price/Sales (TTM) | 7.4 |
Price/Cash Flow (TTM) | 56.8x |
Operating Margin | 17.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
